The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, published by Taylor & Francis Ltd, has established itself as a premier forum for the dissemination of innovative research related to radiation biology, covering emerging topics that are crucial within the fields of radiology, nuclear medicine, and ultrasound technology. With an ISSN of 0955-3002 and an E-ISSN of 1362-3095, this journal spans over six decades, from its inception in 1959 to 2024, reflecting a rich history of scholarly contribution and a dynamic approach to addressing current challenges in the discipline. Its reputation is highlighted by its Q2 rankings in both Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology for 2023, underscoring its relevance in a competitive academic landscape, with Scopus rankings placing it in the top tier of its category. While operating under a traditional access model, the journal aims to connect researchers, professionals, and students, facilitating the advancement of knowledge and fostering a deeper understanding of the impact of radiation in various medical applications. The journal plays an essential role in shaping future research directions and enhancing clinical practices globally.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

Applied Radiation and Isotopes is a premier journal dedicated to the dissemination of high-quality research in the fields of radiation and isotopes, published by PERGAMON-ELSEVIER SCIENCE LTD. With a commendable impact factor reflecting its respected standing, this journal ranks in the Q3 category within Radiation according to the 2023 evaluation, emphasizing its relevance in the scientific community. Operating out of the United Kingdom, it has been a crucial platform for innovation and knowledge sharing since its inception, covering a wide array of applications ranging from the medical to the industrial sectors. Researchers can access a wealth of articles through its online platform, although it currently does not offer open access options. Applied Radiation and Isotopes is thus an essential resource for researchers, professionals, and students aiming to stay abreast of the latest developments in radiation physics and isotopic applications, making impactful contributions to the field.

NUKLEONIKA, published by SCIENDO, is a leading open access journal that has been serving the scientific community since its establishment in 1968. Focused on the domains of Nuclear and High Energy Physics, Condensed Matter Physics, and Nuclear Energy and Engineering, this journal provides a platform for innovative research and technological advancements in a variety of interdisciplinary fields. With an impressive history of publications and a current Q3 ranking in several categories, including Safety, Risk, Reliability and Quality and Waste Management and Disposal, NUKLEONIKA is recognized for its significant contributions to scientific discourse. Open access since 2014, the journal ensures that all research outputs are freely available, facilitating broad dissemination and accessibility for researchers, professionals, and students alike. Located in the heart of Warsaw, Poland, NUKLEONIKA aims to inspire collaborative efforts and foster a deeper understanding of complex physical phenomena and their practical implications.

Journal of Radiological Protection, published by IOP Publishing Ltd, is a pivotal academic journal dedicated to advancing knowledge in the fields of radiology and radiation protection. Since its inception in 1988 and continuing through to 2024, this journal provides a platform for the dissemination of innovative research and critical reviews that explore the effects of radiation exposure on health and the environment. With an Impact Factor that places it among the Q3 category in Medicine, Public Health, Environmental and Occupational Health, as well as in Waste Management and Disposal, the journal is vital for professionals, researchers, and students keen on understanding the implications of radiological science. The Journal of Radiological Protection aims to contribute to improved practices and policies in radiation safety, making its findings essential for those involved in environmental health and public safety initiatives. Articles are accessible through various academic databases, ensuring widespread dissemination among the scientific community, thereby enhancing the journal's stature and influence in radiological research.

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

Journal of Medical Imaging and Radiation Oncology, published by WILEY, is a pivotal resource in the fields of oncology and medical imaging. With an impact factor reflective of its commitment to advancing research, the journal has maintained a robust reputation since its inception in 2008 and continues to thrive through 2024. It is indexed with an insightful ranking, with a Q2 classification in Radiology, Nuclear Medicine and Imaging, affirming its importance in these disciplines. This journal not only serves as an open access platform, allowing extensive reach and accessibility, but also fosters a scholarly community dedicated to the innovation of imaging techniques and radiation oncology practices. As a key player in disseminating crucial findings and advancements, it appeals to researchers, clinicians, and students who aim to contribute to the evolving landscape of medical imaging and cancer treatment methodologies. The journal is based in Australia, at 111 River St, Hoboken, NJ, and invites submissions that push the boundaries of current knowledge in this critical area of healthcare.

RADIOPROTECTION, published by EDP SCIENCES S A, stands as a pivotal journal in the multidisciplinary fields of Nuclear Energy, Public Health, and Environmental Safety. With an ISSN of 0033-8451 and an E-ISSN of 1769-700X, this journal delves into the crucial aspects of radiation protection and its interactions with health and environment, providing a platform for researchers and professionals to disseminate their findings and insights. Despite being classified in the Q4 quartile for Health, Toxicology and Mutagenesis in 2023, its Q3 status in prestigious categories such as Nuclear Energy and Engineering, and Public Health, underscores its relevance in contemporary academic discourse. The journal continues to expand its cachet with converged years of publication from 1977 to 1981 and 1988 to 2024, ensuring a rich history of scholarly contributions. Access options for interested readers include traditional subscriptions, allowing for comprehensive engagement with a broad range of topics surrounding safety, sustainability, and risk management. Whether you are a researcher, professional, or student, RADIOPROTECTION serves as an essential resource for expanding understanding and fostering innovation within its field.